Nassim Usman - 09 Aug 2022 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)

Role
President & CEO, Director
Signature
/s/ Seline Miller, Attorney-in-Fact for Nassim Usman
Issuer symbol
GYRE
Transactions as of
09 Aug 2022
Net transactions value
+$1,528
Form type
4
Filing time
10 Aug 2022, 17:19:56 UTC
Previous filing
16 Feb 2022
Next filing
01 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBIO Common Stock Purchase $1,528 +3,250 +15% $0.4700 24,541 09 Aug 2022 Direct F1
holding CBIO Common Stock 8,456 09 Aug 2022 By The Usman Family Trust
holding CBIO Common Stock 1,168 09 Aug 2022 By Nassim Usman IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2022.